文献速递关节外科创伤骨科

髋部骨折的目标价格调整在改善医疗捆绑支付计划中并不充分

Target Price Adjustment for Hip Fractures Is Not Sufficient in the Bundled Payments for Care Improvement Initiative.
PubMed 文献 · J Arthroplasty · 2020-07-31

该研究比较了4096例全髋关节置换术患者中择期手术、骨折后全髋关节置换和半髋关节置换的医疗费用,发现骨折患者费用超过择期患者两倍以上,且91%的病例超出目标价格,作者建议CMS改变方法或将骨折患者排除在BPCI之外。

要点

  • 骨折后关节置换患者的平均费用比择期全髋关节置换患者高出一倍以上。
  • 骨折后关节置换患者平均亏损23,122美元,而择期全髋关节置换患者平均盈利1,648美元。
  • 骨折后关节置换患者中91%的病例超出目标价格,择期全髋关节置换患者中仅20%超出。

核心结论

  • 骨折后接受关节置换的患者费用是择期全髋关节置换患者的两倍以上。
  • 作者建议CMS改变其方法或将骨折患者排除在BPCI之外,特别是在COVID-19大流行期间。

研究设计与样本

  • 回顾性分析2015年至2018年连续4096例全髋关节置换术患者,分为择期全髋关节置换组(n=3686)、骨折后全髋关节置换组(n=176)和半髋关节置换组(n=274)。
  • 使用CMS索赔数据比较组间住院期间费用、急性后期护理费用及相对于目标价格的执行情况,并进行多变量分析以确定髋部骨折诊断对费用的影响。

主要发现

  • 择期全髋关节置换组的住院期间费用低于半髋关节置换组和骨折后全髋关节置换组(18,200美元 vs 42,605美元 vs 38,371美元;P < .001)。
  • 择期全髋关节置换组的急性后期护理费用低于半髋关节置换组和骨折后全髋关节置换组(4,477美元 vs 28,093美元 vs 23,217美元;P < .001)。
  • 骨折后关节置换患者平均亏损23,122美元,而择期全髋关节置换患者平均盈利1,648美元(P < .001)。
  • 骨折后关节置换患者中91%的病例超出目标价格,而择期全髋关节置换患者中仅20%超出(P < .001)。
  • 多变量分析显示,骨折后关节置换患者的住院期间费用高出19,492美元(P < .001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Under the Bundled Payments for Care Improvement (BPCI) initiative, the Centers for Medicare and Medicaid Services (CMS) adjusts the target price for total hip arthroplasty (THA) based upon the historical proportion of fracture cases. Concerns exist that hospitals that care for hip fracture patients may be penalized in BPCI. The purpose of this study is to compare the episode-of-care (EOC) costs of hip fracture patients to elective THA patients. METHODS: We reviewed a consecutive series of 4096 THA patients from 2015 to 2018. Patients were grouped into elective THA (n = 3686), fracture THA (n = 176), and hemiarthroplasty (n = 274). Using CMS claims data, we compared EOC costs, postacute care costs, and performance against the target price between the groups. To control for confounding variables, we performed a multivariate analysis to identify the effect of hip fracture diagnosis on costs. RESULTS: Elective THA patients had lower EOC ($18,200 vs $42,605 vs $38,371; P < .001) and postacute care costs ($4477 vs $28,093 vs $23,217; P < .001) than both hemiarthroplasty and THA for fracture. Patients undergoing arthroplasty for fracture lost an average of $23,122 (vs $1648 profit for elective THA; P < .001) with 91% of cases exceeding the target price (vs 20% for elective THA; P < .001). In multivariate analysis, patients undergoing arthroplasty for fracture had higher EOC costs by $19,492 (P < .001). CONCLUSION: Patients undergoing arthroplasty for fracture cost over twice as much as elective THA patients. CMS should change their methodology or exclude fracture patients from BPCI, particularly during the COVID-19 pandemic.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Skibicki H, Yayac M, Krueger CA, et al. Target Price Adjustment for Hip Fractures Is Not Sufficient in the Bundled Payments for Care Improvement Initiative. J Arthroplasty. 2020. PMID: 32829971. doi:10.1016/j.arth.2020.07.069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。